11-18303599-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_181507.2(HPS5):​c.896+1823G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.423 in 152,018 control chromosomes in the GnomAD database, including 15,783 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as association (no stars).

Frequency

Genomes: 𝑓 0.42 ( 15783 hom., cov: 31)

Consequence

HPS5
NM_181507.2 intron

Scores

2

Clinical Significance

association no assertion criteria provided O:1

Conservation

PhyloP100: 0.644

Publications

32 publications found
Variant links:
Genes affected
HPS5 (HGNC:17022): (HPS5 biogenesis of lysosomal organelles complex 2 subunit 2) This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. This protein interacts with Hermansky-Pudlak syndrome 6 protein and may interact with the cytoplasmic domain of integrin, alpha-3. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 5. Multiple transcript variants encoding two distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
HPS5 Gene-Disease associations (from GenCC):
  • Hermansky-Pudlak syndrome 5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen
  • Hermansky-Pudlak syndrome without pulmonary fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.572 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HPS5NM_181507.2 linkc.896+1823G>A intron_variant Intron 8 of 22 ENST00000349215.8 NP_852608.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HPS5ENST00000349215.8 linkc.896+1823G>A intron_variant Intron 8 of 22 1 NM_181507.2 ENSP00000265967.5
HPS5ENST00000396253.7 linkc.554+1823G>A intron_variant Intron 7 of 21 1 ENSP00000379552.3
HPS5ENST00000438420.6 linkc.554+1823G>A intron_variant Intron 7 of 21 1 ENSP00000399590.2
HPS5ENST00000531848.1 linkc.554+1823G>A intron_variant Intron 7 of 10 5 ENSP00000431758.1

Frequencies

GnomAD3 genomes
AF:
0.423
AC:
64258
AN:
151900
Hom.:
15779
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.160
Gnomad AMI
AF:
0.646
Gnomad AMR
AF:
0.480
Gnomad ASJ
AF:
0.366
Gnomad EAS
AF:
0.589
Gnomad SAS
AF:
0.489
Gnomad FIN
AF:
0.517
Gnomad MID
AF:
0.323
Gnomad NFE
AF:
0.539
Gnomad OTH
AF:
0.412
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.423
AC:
64276
AN:
152018
Hom.:
15783
Cov.:
31
AF XY:
0.424
AC XY:
31497
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.160
AC:
6630
AN:
41492
American (AMR)
AF:
0.480
AC:
7332
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.366
AC:
1267
AN:
3466
East Asian (EAS)
AF:
0.589
AC:
3041
AN:
5160
South Asian (SAS)
AF:
0.489
AC:
2359
AN:
4820
European-Finnish (FIN)
AF:
0.517
AC:
5452
AN:
10536
Middle Eastern (MID)
AF:
0.327
AC:
96
AN:
294
European-Non Finnish (NFE)
AF:
0.539
AC:
36639
AN:
67960
Other (OTH)
AF:
0.413
AC:
871
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1698
3395
5093
6790
8488
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
582
1164
1746
2328
2910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.486
Hom.:
66433
Bravo
AF:
0.408
Asia WGS
AF:
0.515
AC:
1788
AN:
3478

ClinVar

Significance: association
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

decreased blood alpha-hydroxyisovalerate levels Other:1
May 11, 2014
Human Genetics, Leiden University Medical Centre
Significance:association
Review Status:no assertion criteria provided
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
7.9
DANN
Benign
0.87
PhyloP100
0.64
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2403254; hg19: chr11-18325146; API